Provided by Tiger Trade Technology Pte. Ltd.

ACADIA Pharmaceuticals

29.65
+0.15000.51%
Volume:1.49M
Turnover:44.08M
Market Cap:5.11B
PE:13.50
High:29.78
Open:29.50
Low:29.15
Close:29.50
52wk High:30.96
52wk Low:19.69
Shares:172.31M
Float Shares:128.72M
Volume Ratio:0.95
T/O Rate:1.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):2.20
EPS(LYR):2.30
ROE:35.74%
ROA:3.64%
PB:3.91
PE(LYR):12.89

Loading ...

Aug 02, 2023

Major Issues Report

Form 8-K - Current report
Jul 18, 2023

Major Issues Report

Form 8-K - Current report
Jul 14, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 13, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 15, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 12, 2023

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 02, 2023

Major Issues Report

Form 8-K - Current report
May 24, 2023

Beneficial Ownership Change

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
May 08, 2023

Major Issues Report

8-K - Current report
May 08, 2023

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Mar 13, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Major Issues Report

8-K - Current report
Feb 28, 2023

Annual Report

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Feb 09, 2023

Beneficial Ownership Change

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
Feb 07, 2023

Employee Stock Ownership

S-8 - Securities to be offered to employees in employee benefit plans
Jan 17, 2023

Beneficial Ownership Change

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
Nov 03, 2022

Quarterly Report

10-Q - Quarterly report [Sections 13 or 15(d)]
Nov 02, 2022

Major Issues Report

8-K - Current report
Oct 28, 2022

Major Issues Report

8-K - Current report
Oct 13, 2022

Major Issues Report

8-K - Current report